Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M800113-JLR200 on May 15, 2008 Originally published In Press as doi:10.1194/jlr.M800113-JLR200 on May 13, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M800113-JLR200v1
M800113-JLR200v2
49/9/1884    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lalazar, G.
Right arrow Articles by Ilan, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lalazar, G.
Right arrow Articles by Ilan, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 49, 1884-1893, September 2008
Copyright © 2008 by American Society for Biochemistry and Molecular Biology

β-Glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping

Gadi Lalazar1,*, Ami Ben Ya'acov1,*, Noa Eliakim-Raz*, Dan M. Livovsky*, Orit Pappo{dagger}, Sarah Preston*, Lidya Zolotarov* and Yaron Ilan2,*

* Liver Unit, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel
{dagger} Department of Pathology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel

Published, JLR Papers in Press, May 15, 2008.

This work was supported in part by a grant from The Roman-Epstein Liver Research Foundation (Y. I.).

1 G. Lalazar and A. Ben Ya'acov contributed equally to this work.

2 To whom correspondence should be addressed. e-mail: ilan{at}hadassah.org.il

The aim of this study was to determine the effect of β-glycosphingolipids on intra-hepatic natural killer T (NKT) lymphocyte regulatory function and on lymphocyte trapping via alteration of cell membrane lipid rafts. Immune-mediated colitis was induced by intracolonic instillation of trinitrobenzene sulfonic acid. Mice were treated with β-lactosylceramide (LC), β-glucosylceramide (GC), β-galactosylceramide, ceramide, or a combination of both GC and LC (IGL), or solvent alone. Lipid rafts were investigated by fluorescence-activated cell sorting analysis of ganglioside-GM1 and fluorescence microscopy of structure. Administration of β-glycosphingolipids resulted in an increased intrahepatic/peripheral NKT ratio, increased intrahepatic CD8+ lymphocyte trapping, decreased serum interferon-{gamma} (IFN-{gamma}) levels and decreased serum IFN-{gamma}/interleukin-10 ratio. Administration of GC, LC, or IGL significantly altered the levels of GM1, a key marker of lipid rafts, on NKT regulatory lymphocytes. The immune modulatory effect of β-glycosphingolipids was associated with increased survival and significant alleviation of colitis as determined by improvement in both the macroscopic and microscopic scores. In conclusion, administration of β-glycosphingolipids increased NKT regulatory lymphocyte redistribution and intrahepatic CD8+ T lymphocyte trapping, resulting in alleviation of immune-mediated colitis. The effects of these naturally occurring compounds were associated with modification of the T lymphocyte lipid raft structure, which is a site for immune modulation.

Supplementary key words liver tolerance • lipid rafts • natural killer T cell

Abbreviations: APC, antigen-presenting cell; CTx, cholera toxin; FACS, fluorescence-activated cell sorting; {alpha}-GalCer, {alpha}-galactosylceramide; GC, β-glucosylceramide; GLC, β-galactosylceramide; IFN-{gamma}, interferon-{gamma}; IGL, β-glucosylceramide + β-lactosylceramide; IL-4, interleukin-4; LC, β-lactosylceramide; MHC, major histocompatibility complex; NKT cell, natural killer T cell; TCR, T cell receptor; TNBS, trinitrobenzene sulfonic acid


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Zigmond, S. W. Zangen, O. Pappo, M. Sklair-Levy, G. Lalazar, L. Zolotaryova, I. Raz, and Y. Ilan
{beta}-Glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat
Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E72 - E78.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement